412-246-6111

Quetiapine + Adjunctive Personalized Treatment 

vs.

Lithium + Adjunctive Personalized Treatment

(CHOICE)

 

  

Home     Depression     Bipolar Disorder     Cognitive Therapy     Research     Staff     Contact    TV ADs
 

 

Current Studies

Depression:

* Insomnia & Depression

* Transcranial Magnetic Stimulation (TMS)

* New Medication Trial (ROCHE)

* Buprenorphine for TRD

* New Medication Trial (Shire)

Assessment Only:

* Emotion/Physiology

Bipolar Disorder:

* Quetiapine vs. Lithium

 

**Please note that enrollment has closed for this study**

Purpose

The purpose of this study is to compare the effectiveness of lithium and quetiapine for the treatment of individuals with bipolar disorder.

Eligibility
 
Ages Eligible for Study:   18 Years to 68 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

For further information please call 412-246-6111, click here to email us, or visit clinicaltrials.gov.

 

  
 

If you have any questions or comments about this web site, please contact the webmaster.  For all other questions please click the contact link.

This website was last updated 06/14/2012.

© 2005 Mood Disorders Treatment and Research Program (MDTRP), Department of Psychiatry, Western Psychiatric Institute and Clinic (WPIC), UPMC Health System